Citeline Podcasts

Scrip's Five Must-Know Things - 20 May 2024

20 May 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 17 May 2024. In this episode: the life of a blockbuster; ...

Drug Fix: BIOSECURE Act Advances, Trial Diversity Sticks, Platform Principles Without Designation

17 May 2024

Contributed by Lukas

Pink Sheet editors and reporter consider the implications of the BIOSECURE Act as it advances through a House committee (:30), whether industry would ...

May 2024 Datamonitor Healthcare Podcast: Neoadjuvant Therapy in Melanoma

17 May 2024

Contributed by Lukas

Flora gives an overview of the budding landscape of neoadjuvant therapy in melanoma and provides insight on the nuances of this market. Apple Podcast...

China Biotech Podcast - 15 May 2024 (Chinese- and English-Language)

15 May 2024

Contributed by Lukas

In this bilingual Chinese- and English-language edition, China-based editors Brian Yang and Dexter Yan, along with guest speaker Derrick Gingery from ...

Scrip's Five Must-Know Things - 13 May 2024

13 May 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 10 May 2024. In this episode: AstraZeneca’s Vaxzevria f...

Episode 15: Digital Trust

09 May 2024

Contributed by Lukas

In this episode, Medtech Insight senior reporter Hannah Daniel speaks to Mark Brown, Global Managing Director of Digital Trust Consulting at the Briti...

Solving The Sustainable Pill Pack Puzzle, With PA Consulting’s Tony Perrotta

07 May 2024

Contributed by Lukas

In this episode, HBW Insight chats with sustainable packaging expert Tony Perrotta about why it’s so difficult to replace plastic pill packs in medi...

Scrip's Five Must-Know Things - 7 May 2024

07 May 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 3 May 2024. In this episode: Japan’s Ono buys US oncolo...

Drug Fix: US FDA Adcomm Reform, A Boost For Clinical Trial Modeling, AI For Drug Review

03 May 2024

Contributed by Lukas

Pink Sheet reporter and editors discuss what an upcoming listening session means for the FDA’s advisory committee reform effort (:32), the agency’...

Digital Health Roundup: US FDA’s ‘Idea Lab’; Philips’ Roy Jakobs On AI Draft Framework; Apple Watch

30 Apr 2024

Contributed by Lukas

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights key interviews with Philips’ CEO Roy Jakobs on NAM’s draft fr...

April Datamonitor Podcast 2024: AAN coverage

30 Apr 2024

Contributed by Lukas

Flora and Emma are joined by Datamonitor’s CNS analysts Summer, Joseph, and Wen-Yu to discuss coverage from AAN. Other platforms (in addition to So...

Scrip's Five Must-Know Things - 30 April 2024

30 Apr 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 26 April 2024. In this episode: 2023’s top selling drug...

2024 Global Generics & Biosimilars Awards

29 Apr 2024

Contributed by Lukas

2024 Global Generics & Biosimilars Awards by Citeline

Podcast: Facilitating Patient Monitoring in CAR-T Development

29 Apr 2024

Contributed by Lukas

Learn how molecular technology is enhancing patient safety for CAR-T clinical trials. US FDA recently initiated class safety labeling changes after ...

Drug Fix: US FDA Biosimilar Strategy, Gene Therapy Accelerated Approvals, FDA v. Partisan Politics

26 Apr 2024

Contributed by Lukas

Pink Sheet reporter and editors discuss the impact of FDA biosimilar promotion guidance on the future of the interchangeability designation (:34), upc...

Dr. Xue Discusses Treatment Guideline Updates for COPD in This Q&A Session

26 Apr 2024

Contributed by Lukas

Pulmonologist Bing Xue, MD, reviews the latest GOLD guidelines and discusses relevant topics regarding COPD treatment.

China Biotech Podcast - 26 April 2024 (Chinese and English Language)

26 Apr 2024

Contributed by Lukas

Join Scrip's China-based editors Brian Yang and Dexter Yan in this Chinese/English podcast as they look at data presented to AACR by Chinese pharma fi...

Future Governance & Oversight of the EU Medtech Regulatory System

24 Apr 2024

Contributed by Lukas

Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadl...

Citeline - Cerba Research Podcast V2

23 Apr 2024

Contributed by Lukas

Citeline - Cerba Research Podcast V2 by Citeline

Scrip M&A Podcast: Are Buyers Coming For Viking, Verona, Altimmune, Xenon And Crinetics

23 Apr 2024

Contributed by Lukas

Scrip's Joseph Haas, Kevin Grogan and Edwin Elmhirst talk about the biopharma M&A environment and which companies might look particularly appealing to...

Turning That Frown Upside Down: Treating Depression With Facial Botox Injections

22 Apr 2024

Contributed by Lukas

In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumati...

Helping Consumers ‘Tune In’ To Reliable Health Information, With Kaizo’s Anita Nahal

22 Apr 2024

Contributed by Lukas

Helping Consumers ‘Tune In’ To Reliable Health Information, With Kaizo’s Anita Nahal “Consumers are rewriting the rules when it comes to wher...

Scrip's Five Must-Know Things - 22 April 2024

22 Apr 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 19 April 2024. In this episode: Teva’s immunology biosi...

Drug Fix: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

19 Apr 2024

Contributed by Lukas

Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi (:28), Janet Woodcock’s new post-FDA role (12:28), ...

Next-Generation Diagnostics: "Breathomics" From Imspex

19 Apr 2024

Contributed by Lukas

A new diagnostic technology to screen and triage individuals based on breath.

Ratio Therapeutics On BMS Buy-In, Radiopharma R&D Trends, AI And Assets

16 Apr 2024

Contributed by Lukas

Scrip’s senior editor Vibha Ravi speaks with Jack Hoppin, CEO and chairman, and John Babich, chief scientific officer, at Ratio Therapeutics, about ...

China Biotech Podcast (Chinese- and English-language) - April 2024

15 Apr 2024

Contributed by Lukas

In this Chinese- and English-language episode, guest speaker Treehill Partners co-founder Ali Parshadezah joins Brian Yang and Dexter Yan to discuss u...

Scrip's Five Must-Know Things - 15 April 2024

15 Apr 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 12 April 2024. In this episode: the shifting sands of pha...

Drug Fix: US FDA Adcomm Open Public Hearings, Clinical Trial Diversity Plans, Stealth’s Elamipretide

12 Apr 2024

Contributed by Lukas

Pink Sheet reporter and editors discuss Richard Pazdur’s call for more diverse opinions in FDA advisory committee meeting open public hearings (:36)...

In Conversation With 2024 In Vivo Rising Leader, Hanadie Yousef

09 Apr 2024

Contributed by Lukas

In this episode, In Vivo speaks to 2024 Rising Leader Hanadie Yousef, CEO of Juvena Therapeutics, about her journey, the secretome as a source of ther...

Scrip's Five Must-Know Things - 8 April 2024

08 Apr 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 5 April 2024. In this episode: Genmab buys into ADCs; Roi...

Drug Fix: Relyvrio And Public Promises, Allergy Biomarker Adcomms, PMDA In The USA

05 Apr 2024

Contributed by Lukas

Pink Sheet reporters and editor discuss the implications of Amylyx following through on its pledge to remove Relyvrio from the market after its trial ...

Medtech Connect Episode 14: Live From HIMSS 2024

03 Apr 2024

Contributed by Lukas

In this episode, Medtech Insight regulatory reporter Hannah Daniel speaks to industry professionals at the Healthcare Information and Management Syste...

피노바이오, 국내 ADC 생태계 발전에 기여할 것 (Korean-language podcast)

02 Apr 2024

Contributed by Lukas

기술 수요와 공급의 '불균형' 속에서 국내 ADC 업체들은 생태계를 발전시키려 노력하고 있습니다.  Scrip의 정두영 ...

Scrip's Five Must-Know Things - 1 April 2024

01 Apr 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Merck & Co progresses cardiovascular str...

Analysing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen

28 Mar 2024

Contributed by Lukas

In this episode, HBW Insight’s Europe and US editors Tom Gallen and Malcolm Spicer bring their expertise to bear on the current the trend towards st...

March Datamonitor Podcast 2024: The US Inflation Reduction Act

27 Mar 2024

Contributed by Lukas

Flora and Ian are joined by Datamonitor’s financial analyst Abby, who discusses the Inflation Reduction Act and drug pricing trends in the US. Other...

Scrip's Five Must-Know Things - 26 March 2024

26 Mar 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: another big deal in radiopharmaceuticals...

Drug Fix: Mifepristone And Misinformation At SCOTUS, Understanding US FDA’s ODAC

22 Mar 2024

Contributed by Lukas

Pink Sheet reporters and editor discuss the upcoming US Supreme Court arguments on mifepristone access (:34), the SCOTUS reaction to the fight against...

China Biotech Podcast (Chinese language) - March 2024

22 Mar 2024

Contributed by Lukas

Guest speaker Kevin Duan joins Brian Yang and Dexter Yan to discuss the proposed US BIOSECURE Act, the US FDA's approval of a China-origin anti-PD-1 d...

Digital Health Roundup: EU’s AI Act Impact; Verily's Andrew Trister’s Vision For Personal AI Agent

20 Mar 2024

Contributed by Lukas

Listen to the podcast via the player below: Medtech Insight articles addressing topics discussed in this episode: In Five Years, People Will Navigat...

Scrip's Five Must-Know Things - 18 March 2024

18 Mar 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Galderma prepares to take on Dupixent; P...

How AI Is Revolutionizing Personalized Wellness, With Bioniq’s Marni Allen

15 Mar 2024

Contributed by Lukas

In this episode, HBW Insight dives into personalized wellness with Marni Allen, chief marketing officer at tailored supplements manufacturer Bioniq. N...

【3分で解説 世界のファーマ】第17回 LSDで不安症を治療 第III相開始へ (Japanese-language podcast)

13 Mar 2024

Contributed by Lukas

Summary: 今回取り上げた記事はこちら 「MindMed Ready To Take LSD Therapy Into Phase III For Anxiety（MindMed、LSD療法を不安症治療...

"Identifying The 80% Of Undiagnosed And Misdiagnosed Patients"

11 Mar 2024

Contributed by Lukas

Vibhor Gupta, director and founder of Pangaea Data, talks to In Vivo about the value of identifying the 80% of patients with undiagnosed or misdiagnos...

Scrip's Five Must-Know Things - 11 March 2024

11 Mar 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Bayer won’t split, for now; Pfizer’s...

Drug Fix: Vanda Appeals US FDA Jet Lag Denial In Court, Mark Cuban Battles PBMs, Austere FDA Budget

08 Mar 2024

Contributed by Lukas

Pink Sheet reporters and editor discuss Vanda’s decision to sue the FDA over the rejection of the Hetlioz jet lag indication (:30), Mark Cuban’s c...

Scrip이 묻다: 2024년 제약바이오업계 전망은? 치료영역의 발전 (Korean-language podcast)

07 Mar 2024

Contributed by Lukas

2024년 글로벌 전문가들이 예측하는 치료영역의 발전은 무엇인 지에 대한 Scrip 기사를 요약한 내용입니다 https://scr...

Medtech Connect Episode 13: Augmented Reality In Surgery

07 Mar 2024

Contributed by Lukas

In this episode, US regulatory reporter Hannah Daniel speaks to Ocutrx CEO Michael Freeman about augmented reality in medical products and their not-s...

Scrip's Five Must-Know Things - 4 March 2024

04 Mar 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: optimistic outlook for biopharma IPOs; B...

Cardio Conversations: iRhythm CEO Blackford Talks AI Arrhythmia Diagnostics

04 Mar 2024

Contributed by Lukas

iRhythm CEO Quentin Blackford returns to Medtech Insight’s Cardio Conversations podcast to talk about the launch of the company’s new Monitor long...

The Emerging Benefits Of ‘Beauty-From-Within,’ Featuring Kenvue’s Paul LaTerra

01 Mar 2024

Contributed by Lukas

In this episode of Over the Counter, HBW Insight speaks to Paul LaTerra, Director, R&D, Global Hair and Scalp for Kenvue, a New Jersey-based consumer ...

February Datamonitor Podcast: 2024 Clinical Outlook

28 Feb 2024

Contributed by Lukas

Emma and Flora outline expected trends and exciting upcoming events across therapy areas for 2024, straight from the subject matter experts at Datamon...

NodThera On The Role Of The Brain In Driving Chronic Disease

28 Feb 2024

Contributed by Lukas

Alan Watt, CEO of NodThera, a clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to treat chronic inflammatory diseases, ...

Scrip's Five Must-Know Things - 26 February 2024

26 Feb 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Bayer takes strategic steps to cut debt;...

Drug Fix: US FDA And Psychedelic Drugs, Aduhelm Clinical Trial Data, Adcomm Candidates

23 Feb 2024

Contributed by Lukas

Pink Sheet reporters and editors discuss the FDA’s approach to psychedelic drugs (:25), whether postmarket clinical trial data from the Alzheimer’...

AESGP’s 60th Birthday Celebrations In 2024 Including Annual Meeting, With Jurate Švarcaite

20 Feb 2024

Contributed by Lukas

The Association of the European Self-Care Industry celebrates its 60th birthday this year. In this episode, we catch up with AESGP director general, J...

Drug Fix: Price Negotiation Suit Tossed, Drug Shortage Probe, FDA-Approved Marijuana

16 Feb 2024

Contributed by Lukas

Pink Sheet reporters and editors discuss the dismissal of PhRMA’s suit challenging the Medicare price negotiation provisions (:30), the US FTC and H...

Drug Fix: State Of The Generic Industry, US FDA Under Second Trump Term, Inspections And Shortages

09 Feb 2024

Contributed by Lukas

Pink Sheet reporter and editors discuss the issues and concerns raised during a major generic industry conference (:42), former FDA Commissioner Scott...

China Biotech Podcast (Chinese and English Language) - February 2024

08 Feb 2024

Contributed by Lukas

Brian Yang, Dexter Yan and UK-based Kevin Grogan discuss Shanghai's new policy, draft US Biosecure bill, and multinationals AstraZeneca and Sanofi exe...

혁신 육성 전략에 기반한 한국의 제약바이오 강국 야망 (Korean-language podcast)

07 Feb 2024

Contributed by Lukas

박민수 보건복지부 2차관은 Citeline의 Pink Sheet과의 인터뷰에서 정부의 혁신적 R&D 우선순위와 이같은 목표 달성을 위...

Trio Of Diagnostics Execs Weigh In On Upcoming Challenges

06 Feb 2024

Contributed by Lukas

During this episode, Barnaby Pickering is joined by Rollie Carlson, CEO of Immunexpress, developer of Septicyte, a test for sepsis, Mark McDonough, CE...

China Biotech Podcast - Interview With BeiGene Co-Founder Xiaodong Wang

06 Feb 2024

Contributed by Lukas

Xiaodong Wang of major Chinese pharma firm BeiGene and China's National Institute of Biological Sciences shares views on China biotech innovation, Bei...

Title: The Promise Of AI For Consumer Health, Pt 2, With The Exponential Club’s Nick Tate

05 Feb 2024

Contributed by Lukas

HBW Insight continues its conversation with The Exponential Club’s Nick Tate. In this episode, we discuss what the future of consumer health might a...

Scrip's Five Must-Know Things - 5 February 2024

05 Feb 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: the biggest drug launches expected in 20...

Digital Health Roundup: CES Biggest Hits; Apple Versus Masimo; Insulet Recalls Diabetes App

30 Jan 2024

Contributed by Lukas

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights interviews with industry leaders in medtech and healthtech and de...

Automating Cell Therapy Manufacturing: Cellular Origins' CEO Talks Robotics

29 Jan 2024

Contributed by Lukas

In the latest episode of the In Vivo podcast, Edwin Stone, CEO of UK-based Cellular Origins, talks about how robotics can increase access to safe cell...

Scrip's Five Must-Know Things - 29 January 2024

29 Jan 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Bayer’s pipeline refresh; J&J’s sele...

Medtech Connect Episode 12: Apple’s Patent Infringement Cases

26 Jan 2024

Contributed by Lukas

Medtech Insight regulatory reporter Hannah Daniel speaks to Sanjay Voleti, AliveCor’s chief business officer, about his company’s patent infringem...

Drug Fix: Janet Woodcock And The US FDA’s G.O.A.T., Puberty Blockers Meeting, CAR-T Safety

26 Jan 2024

Contributed by Lukas

Pink Sheet reporters and editor discuss FDA Principal Deputy Commissioner Janet Woodcock’s place in the pantheon of FDA leaders (:27), an agency mee...

Q&A Session on Treatment of LBCL With Oncologist Donald Fleming, MD

22 Jan 2024

Contributed by Lukas

In this discussion, Dr. Fleming provides expert insight to questions about treating LBCL in elderly patients and those with comorbidities.

The Promise Of AI For Consumer Health, Pt 1, With The Exponential Club’s Nick Tate

22 Jan 2024

Contributed by Lukas

In this episode, HBW Insight speaks to The Exponential Club’s Nick Tate about the impact of artificial intelligence and digitalization on consumer h...

Drug Fix: US FDA Adcomm Schedule, CMS And Drug Importation, Missed User Fee Goals

19 Jan 2024

Contributed by Lukas

Pink Sheet reporters and editors discuss the nearly wide open 2024 FDA advisory committee calendar, CMS’s impact on Florida’s drug importation pla...

China Biotech Podcast - Major Takeaways From JPM (January 2024 - Chinese-Language)

19 Jan 2024

Contributed by Lukas

VelaVigo founder and CEO Jing Li in Shanghai joins guest speaker Leon Tang in the US and Brian Yang in Beijing to discuss what stood out in this speci...

【3分で解説 世界のファーマ】第16回 JPモルガンで見えた2024年の製薬業界 (Japanese-language podcast)

19 Jan 2024

Contributed by Lukas

（日本語版）今回取り上げた記事はこちら 「J.P. Morgan 2024: Optimism With An Undercurrent Of Tension（J.P.モルガン2024年：緊...

Scrip's Five Must-Know Things - 15 January 2024

15 Jan 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: major takeaways and highlights from the ...

Pennine Health Talks Sustainability Compliance and ESG Initiatives

12 Jan 2024

Contributed by Lukas

Pennine Health Talks Sustainability Compliance and ESG Initiatives by Citeline

Drug Fix: Project Orbis For Gene Therapy, US FDA Leaders’ 2024 Predictions, FDA and AI

12 Jan 2024

Contributed by Lukas

Pink Sheet reporter and editors discuss a new pilot project allowing collaborative reviews of gene therapies by multiple regulators (:42), predictions...

Building A Biotech: Exploring ILC’s Hybrid Interferon Platform

11 Jan 2024

Contributed by Lukas

In the latest episode of the In Vivo podcast, non-executive chair Peter Bains and Owain Millington, vice president of immunology and head of preclinic...

전 세계 비만 치료제 임상시험 건 수, 미국이 가장 높아…한국은 9위 (Korean-language podcast)

11 Jan 2024

Contributed by Lukas

Join Jung Won Shin for this Korean-language mini podcast talking about a report from Citeline's Datamonitor Healthcare. Datamonitor Healthcare의 비...

Scrip's Five Must-Know Things - 10 January 2024

10 Jan 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: 2023 drug launch highlights; the M&A out...

Podcast: Current trends in the biotech landscape with Chris Smyth, President, ICON Biotech Solutions

09 Jan 2024

Contributed by Lukas

Listen as Chris Smyth, President, ICON Biotech Solutions discusses current trends in the biotech landscape, and predictions for future innovation, reg...

China Biotech Podcast - January 2024 (Chinese-language)

09 Jan 2024

Contributed by Lukas

One week into 2024, there have already been multiple deals between Chinese innovative drug developers and multinational and the significant acquisitio...

Cardio Conversations: AVS Cracks Calcium With Novel Pressure Wave Balloon

05 Jan 2024

Contributed by Lukas

In this edition of Cardio Conversations, Medtech Insight editor Reed Miller talked to Robert Chisena, the co-founder and CTO of AVS. He talked about t...

Drug Fix: Looking Back And Looking Ahead: Key US and EU Legislation

05 Jan 2024

Contributed by Lukas

Pink Sheet reporter and editors discuss key US and EU legislation that impacted 2023 and how it also could affect 2024, including EU legislative refor...

Unlock the Future of Cancer Detection with Dr Charles P. Vega, MD, FAAFP: Listen Now!

03 Jan 2024

Contributed by Lukas

Join us for an insightful Q&A session with Dr. Vega, where we delve into the groundbreaking world of Multi-Cancer Early Detection (MCED) and the futur...

The Challenges of Rare Neurological Disease Drug Development

22 Dec 2023

Contributed by Lukas

In this episode, In Vivo speaks to Bruce Leuchter, CEO of Neurvati Neurosciences, about ways clinical drug development in rare neurologic diseases is ...

【3分で解説 世界のファーマ】第15回 治験に被験者の「多様性」を 米国の課題 (Japanese-language podcast)

22 Dec 2023

Contributed by Lukas

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...

Medtech Connect Episode 11: A Look Back At 2023

20 Dec 2023

Contributed by Lukas

In this episode, Medtech Insight regulatory reporter Hannah Daniel speaks to King & Spalding’s Eric Henry about the year’s most influential digita...

Biopharma’s Must-Know 2023-4 Catalysts

20 Dec 2023

Contributed by Lukas

In this podcast Scrip looks at the some upcoming clinical catalysts for biopharma, judged by the size of the sales forecasts at stake. Companies inclu...

Scrip’s Five Must-Know Things – 19 December 2023

19 Dec 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: first ever gene editing FDA nod; US FTC ...

Drug Fix: Taking A Look Back, And Forward, With US FDA’s Project Orbis

15 Dec 2023

Contributed by Lukas

Pink Sheet reporters and editors in the US and Europe consider the growth and impact of Project Orbis after a year in which two major regulators joine...

China Biotech Podcast - December 2023 (Chinese-language)

14 Dec 2023

Contributed by Lukas

Brian Yang and Dexter Yan discuss Biokin/BMS's ADC deal, WuXi Biologics' share price drop, BlissBio's recent developments and Pfizer's divestment of P...

Scrip’s Five Must-Know Things – 11 December 2023

11 Dec 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: another acquisition for AbbVie; Roche bu...

Over the Counter 7 Dec 2023: IFRA On Potential Impact Of EU's CLP Revision

07 Dec 2023

Contributed by Lukas

In this episode, HBW Insight speaks to Aurélie Perrichet, regional director, Europe at the International Fragrance Association. We discussed the impl...

제약업계의 생성형AI 적용 성공의 열쇠는? (Korean-language podcast)

05 Dec 2023

Contributed by Lukas

최근 제프리스 헬스케어 컨퍼런스에서 발표된 제약바이오산업의 생성형인공지능 적용사례에 대한 Scrip 기사를 요...

Scrip's Five Must-Know Things - 4 December 2023

04 Dec 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: CAR-Ts and malignancies; comeback for GS...

Drug Fix: CAR-T Malignancy Reports, Background Music In DTC Ads, New No. 2 At US FDA

01 Dec 2023

Contributed by Lukas

Pink Sheet reporter and editors discuss the FDA acknowledging reports of malignancies in patients who received CAR-T cell immunotherapies (:35), the a...

RNA And Kidneys And Diagnostics RNA, Oh My – Discussing Verici DX’s Differentiated Product Offering

27 Nov 2023

Contributed by Lukas

In this podcast, In Vivo speaks to Sara Barrington, CEO of Verici DX. During the discussion, Barrington outlines the current challenges facing patient...

Scrip’s Five Must-Know Things – 27 November 2023

27 Nov 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Bayer’s Phase III failure; US group se...